Overview

Safety of Estrogens in Lupus: Birth Control Pills

Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether women with systemic lupus erythematosus (SLE or lupus) can safely use estrogen. We will determine this by looking at the effects of oral contraceptives (birth control pills, also known as "the pill") on disease activity and severity in women with SLE. The results of the study will show whether it is safe for women with SLE to use the pill.
Phase:
Phase 3
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Collaborators:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Office of Research on Women's Health (ORWH)
Treatments:
Contraceptive Agents
Contraceptives, Oral
Estrogens
Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination
Norinyl